Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models
- 9 September 2021
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (5), 2101186
- https://doi.org/10.1183/13993003.01186-2021
Abstract
Statistical constructs such as ROC/AUC do not answer the critical question of how much clinical utility a risk prediction model confers. This paper overviews decision curve analysis, a novel method for quantifying net benefit of a risk prediction model. https://bit.ly/3h1rraXKeywords
Funding Information
- BC SUPPORT Unit Methods Cluster Project Award (HESM 205)
This publication has 15 references indexed in Scilit:
- Calibration: the Achilles heel of predictive analyticsBMC Medicine, 2019
- Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisalBMJ, 2019
- A simple, step-by-step guide to interpreting decision curve analysisDiagnostic and Prognostic Research, 2019
- The Importance of Uncertainty and Opt-In v. Opt-Out: Best Practices for Decision Curve AnalysisMedical Decision Making, 2019
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019European Respiratory Journal, 2019
- Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and UglyThe American Journal of Medicine, 2015
- Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohortsBMJ Open, 2012
- Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)European Respiratory Journal, 2008
- Use and Misuse of the Receiver Operating Characteristic Curve in Risk PredictionCirculation, 2007
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006